Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Multi-Center Medication Reconciliation Quality Improvement Study
NCT01337063 · View on ClinicalTrials.gov ↗
Study Summary
Patients often have problems after they leave the hospital, in part because errors are made in the medications they are prescribed. The goal of this project is to develop a more accurate and safe medication prescription process when patients enter and leave the hospital and implement this process at six U.S. hospitals. The investigators will measure the success of the project and develop lessons learned so this process can be applied to other hospitals.
Conditions Studied
Interventions
- OTHER Mentored medication reconciliation quality improvement
Study Locations (6)
California
- University of California, San Francisco — San Francisco
Georgia
- Emory Johns Creek Hospital — Johns Creek
Illinois
- University of Chicago Hospitals and Clinics — Chicago
Massachusetts
- Baystate Health — Springfield
North Carolina
- Presbyterian Hospital — Charlotte
South Dakota
- Sioux Falls VA Medical Center — Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,836 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01337063
The ClinicalTrials.gov registry entry for NCT01337063 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,836 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 929 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Adverse Drug Events appearing as the primary indexed condition, and to 1 intervention — of which Mentored medication reconciliation quality improvement is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01337063 reports 6 study locations spanning 6 distinct geographic areas — top geographies include California, Georgia, Illinois. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01337063 about?
NCT01337063 is a clinical study titled "Multi-Center Medication Reconciliation Quality Improvement Study". Patients often have problems after they leave the hospital, in part because errors are made in the medications they are prescribed. The goal of this project is to develop a more accurate and safe medication prescription process when patients enter and leave the hospital and implement this process at...
What is the current status of trial NCT01337063?
This trial is currently completed. It is a NA study. The enrollment target is 1,836 participants. The study started on 2011-03. Estimated completion is 2014-09.
What conditions does trial NCT01337063 study?
This clinical trial studies the following conditions: Adverse Drug Events, Medication Administered in Error. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT01337063?
The interventions under investigation include: Mentored medication reconciliation quality improvement (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT01337063?
This trial is sponsored by Brigham and Women's Hospital, which has 929 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01337063 being conducted?
This trial has 6 study locations across California, Georgia, Illinois, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.